PUI
VTAK icon

Purpose Unlimited Inc’s Catheter Precision VTAK Stock Holding History

Purpose Unlimited Inc’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13 Hold
13
– – ﹤0.01% 570
2025
Q4 		$23 Buy
+13
New +$30 ﹤0.01% 398

Other funds holding VTAK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Purpose Unlimited Inc's VTAK Position: Q1 2026 in Review

Purpose Unlimited Inc held its Catheter Precision (VTAK) position steady in Q1 2026 at 13 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Purpose Unlimited Inc first reported a position in VTAK in Q4 2025 and has held it in 2 quarters since. The position peaked at $23 in Q4 2025. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Purpose Unlimited Inc held 13 shares of Catheter Precision worth $13 as of Q1 2026.
  • Purpose Unlimited Inc left its Catheter Precision share count unchanged in Q1 2026.
  • Catheter Precision made up ﹤0.01% of Purpose Unlimited Inc's portfolio in Q1 2026, its #570 holding.
  • Purpose Unlimited Inc first reported a position in Catheter Precision in Q4 2025 and has held it in 2 quarters since.
  • Purpose Unlimited Inc's Catheter Precision position peaked at $23 in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Purpose Unlimited Inc's 13F filing for Q1 2026, filed 15 May 2026.